MedTrace Logo

Marijuana for HIV-Related Peripheral Neuropathy

NCT00046722 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2007-06-14

No results posted yet for this study

Summary

To evaluate whether smoked marijuana reduces pain in people with HIV-related peripheral neuropathy.

Conditions

  • Peripheral Nervous System Diseases
  • HIV Infections

Interventions

DRUG

Smoked Marijuana

Sponsors & Collaborators

  • Center for Medicinal Cannabis Research

    lead OTHER

Principal Investigators

  • Donald I Abrams, M.D. · UCSF Community Consortium

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-01-31
Completion
2005-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00046722 on ClinicalTrials.gov